Federal agencies have removed web pages dedicated to DEI programs related to cancer research and other clinical research.

Food insecurity in pregnancy is associated with an increased risk for perinatal complications, according to a recent study.

Children with rheumatic diseases may face increased risks for COVID-19-related hospitalization, particularly those using glucocorticoids, rituximab, or mycophenolate.

The Food and Drug Administration has approved Journavx (suzetrigine) for the treatment of moderate to severe acute pain in adults.

Patients with rheumatoid arthritis are associated with an increased risk for heart failure, particularly heart failure with preserved ejection fraction.

The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.

A recent study finds that genetically predicted rheumatoid arthritis is causally associated with prostate cancer.

Researchers examined the long-term effect of different responses to pediatric obesity treatment on critical health outcomes in young adulthood.

Patients with CKD who use antiresorptive drugs for tumor-related disorders or oral corticosteroids may be at increased risk for osteonecrosis of the jaw.

Long-term TNFi use in patients with psoriasis was not associated with a higher risk of cancer, including lymphoma, prostate cancer, and breast cancer.

For young individuals with cancer, residence in redlined neighborhoods is associated with lower survival at five and 10 years.

Patients with axSpA and early-stage hypertension face elevated risks for CVEs, likely due to their high inflammatory burden.